The fungal derivative called halofungin reduced the overproduction of collagen by inhibiting TGF-β in a human breast cancer orthotopic mouse model [182], while other researchers used collagenase to reduce the stiffness of the tumor matrix for better drug penetration [183]. Here, TGFB1 is linked to breast carcinoma.